What if the most telling number in a grey hair trial isn't how much hair improved, but how much the placebo group got worse? In a new randomized, double-blind study, people taking a supplement and using a serum saw their grey hair count fall by 13.0% over 24 weeks. Volunteers on a double placebo ended up with 9.7% more grey hairs than they started with.
The study, published in the Journal of Drugs in Dermatology (2026), is notable for what it claims. Its authors say no treatment had previously been shown in a clinical trial to repigment or slow the development of grey hair.
The Problem: Grey Is Nearly Universal
The paper opens with a striking statistic. Worldwide, 74% of men and women between 45 and 65 have some grey hair. Despite how common it is, the researchers note there is currently no treatment backed by clinical trial evidence for repigmenting grey hair or slowing its development. Most of the market consists of dyes that cover grey hair rather than address it.
That gap is what this trial tried to fill, using a two-part regimen from Two Lines Inc.: To The Root® serum (topical) and Not Today Grey (oral supplement).
How the Trial Was Built
The design is stronger than many consumer-product studies:
- 173 men and women aged 28 to 65 completed the study
- All had 5–25% grey hair at the start, so these were early-to-moderate greys, not fully silver heads
- It was randomized, double-blind and placebo-controlled
- It ran for 24 weeks, with at least 40 participants in each of four groups
The four arms were:
- Combination: supplement + serum
- Supplement only: supplement + placebo serum
- Serum only: serum + placebo supplement
- Placebo: placebo supplement + placebo serum
The four-arm layout is what allows the study to ask whether the two products work alone or need each other.
The Headline Numbers
The combination group's results:
- Week 12: a 9.2% reduction in grey hair (P=0.034 vs baseline)
- Week 24: a 13.0% reduction (P=0.016 vs baseline)
The placebo group moved the other way. Its mean number of grey hairs rose 9.7% from baseline to week 24. Comparing the combination group with placebo at week 24 gave P=0.004, a statistically significant difference.
The researchers describe the combination result as both statistically significant and clinically meaningful.
It Wasn't Just a Hair Count
It is fair to ask whether counting hairs could be subjective or noisy. The authors report two other measures that pointed the same way:
- Photo grading of grey hair: P=0.002 for week 24 vs baseline
- Subject observation, meaning participants' own assessment: P=0.002 vs baseline
When objective-style grading and the participants' own perceptions agree, the finding is harder to dismiss as a measurement quirk.
The Fine Print: Combination, Not Individual Products
The abstract credits the results to "synergistic effects" of the proprietary blends in the oral supplement and the patented topical serum. The benefit was demonstrated for the combination. The abstract does not report significant effects for the supplement alone or the serum alone, so it would be inaccurate to say a supplement by itself reduces grey hair based on this paper.
Two other limits are worth stating plainly:
- The ingredients aren't listed in the abstract. The products are described only as proprietary blends, which makes it impossible to say from the abstract what is doing the work, or to compare the formulas with other products.
- The products come from one company. The study tested Two Lines Inc. products. Readers should check the full paper's disclosures and funding statements, and independent replication would add confidence.
Practical Takeaways
What the combo result means
The positive finding belongs to the supplement and serum used together. Based on the abstract, you shouldn't assume that buying one half of the regimen delivers the same effect.
Set realistic expectations
A 13.0% reduction in grey hair count is a reduction, not a full reversal. Participants started with only 5–25% grey hair, and nothing in the abstract suggests that a head of grey would return to its original color. Think "fewer greys than before," not "youthful color restored."
Remember the placebo comparison
The placebo group got about 10% greyer over the same period. That makes the gap between the combination and placebo groups larger than the 13% figure alone suggests, and it is the comparison the authors used for their significance test (P=0.004).
Who this is relevant for
The evidence applies most directly to adults aged 28–65 with early to moderate greying (5–25%). The abstract says nothing about people with predominantly grey or white hair, so those results shouldn't be extrapolated to them.
Stay critical
A single trial, proprietary formulas and one manufacturer's products are reasons for optimism rather than certainty. The result is promising, but it is no reason to abandon caution about supplement claims. Check ingredient lists for allergens and talk to a clinician before adding a supplement, especially if you take medication or have a medical condition.
The Bottom Line
Grey hair has long been treated as inevitable, and this trial is an early sign that it may be modifiable. Over 24 weeks, a supplement-plus-serum regimen cut grey hair counts by 13.0% while placebo users got 9.7% greyer. The next steps are independent replication, disclosure of what is in the blends, and data on whether each product contributes on its own.